93 related articles for article (PubMed ID: 27387314)
1. [Not Available].
Pajonk FG
MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 27387314
[TBL] [Abstract][Full Text] [Related]
2. [Longterm treatment of schizophrenia].
Pajonk VF
MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
[TBL] [Abstract][Full Text] [Related]
3. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
[TBL] [Abstract][Full Text] [Related]
4. The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia.
Tarrier N; Bobes J
Int J Psychiatry Clin Pract; 2000; 4(1):35-51. PubMed ID: 24927310
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptics--psychotherapy--psychiatric social work. In schizophrenia help is needed from many sides].
Klingberg S; Längle G; Buchkremer G
MMW Fortschr Med; 2003 Oct; 145(41):28-31. PubMed ID: 14655477
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute and chronic psychoses in childhood and adolescence].
Eggers Ch
MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
[TBL] [Abstract][Full Text] [Related]
7. [Relapse in schizophrenia: an exploratory study of the joint conceptions of patients, parents and caregivers].
Koenig M; Castillo MC; Urdapilleta I; Le Borgne P; Bouleau JH
Encephale; 2011 Jun; 37(3):207-16. PubMed ID: 21703436
[TBL] [Abstract][Full Text] [Related]
8. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
9. [Modification of long-term schizophrenia by somato-therapeutic measures].
Gross G; Huber G; Schüttler R
Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
Schooler NR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
[TBL] [Abstract][Full Text] [Related]
12. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up treatment of schizophrenic psychoses: advantages and disadvantages of long-term medication].
Steuber H; Kind J; Lohrengel S; Müller P
Arzneimittelforschung; 1978; 28(9):1492-3. PubMed ID: 38806
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the combination of psychosocial and pharmacological treatment in schizophrenic patients].
Valencia Collazos M; Ortega Soto HA; Rascón Gasca ML; Gómez Caudillo L
Actas Esp Psiquiatr; 2002; 30(6):358-69. PubMed ID: 12487946
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of relapse prevention in schizophrenia.
Müller N
Pharmacopsychiatry; 2004 Nov; 37 Suppl 2():S141-7. PubMed ID: 15546066
[TBL] [Abstract][Full Text] [Related]
16. Partial compliance in schizophrenia and the impact on patient outcomes.
Llorca PM
Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy in schizophrenia--comparison of second generation antipsychotic agents].
Melamed Y; Finkel B; Barak Y; Zipris P; Oyffe I; Weizman A; Bleich A
Harefuah; 2005 Apr; 144(4):285-90, 301. PubMed ID: 15889614
[TBL] [Abstract][Full Text] [Related]
18. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
Müller-Spahn F; Modell S; Thomma M
Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
[TBL] [Abstract][Full Text] [Related]
19. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy of persons with schizophrenia.
Carpenter WT
J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
